Article info
PDFBrief report
Psychotropic drugs and paediatrics: a critical need for more clinical trials
- Correspondence to Dr Carl L Tishler, Department Psychology, The Ohio State University, 1776 East Broad Street, Columbus, OH 43203, USA; tishler.1{at}osu.edu
Citation
Psychotropic drugs and paediatrics: a critical need for more clinical trials
Publication history
- Received May 19, 2011
- Revised September 20, 2011
- Accepted October 2, 2011
- First published November 2, 2011.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Prerequisites to support high-quality clinical trials in children and young people
- Challenges in clinical trials for children and young people
- Informed consent and assent guide for paediatric clinical trials in Europe
- Non-static framework for understanding adaptive designs: an ethical justification in paediatric trials
- StaR Child Health: developing evidence-based guidance for the design, conduct and reporting of paediatric trials
- A systematic review of paediatric randomised controlled drug trials published in 2007
- Informed consent for paediatric clinical trials in Europe
- Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee
- PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it
- Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary